Current surveillance data from the WHO and CDC show no novel pathogen achieving sustained human-to-human transmission at global scale, underpinning the 89.5% market-implied probability against a new pandemic declaration in 2026. A May hantavirus cluster aboard the M/V Hondius cruise ship triggered brief trader concern over three fatalities, yet the Andes strain’s droplet-based spread and low reproductive number in non-confined settings have kept risks localized per epidemiological assessments. Ongoing H5N1 avian influenza and mpox clade IIb cases remain contained without exponential growth or public health emergency escalation. With over four months elapsed and robust multi-pathogen monitoring in place, traders weigh the historical rarity of pandemics against these stable conditions.